ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,425Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 749

$438K Total Retail Price of All Prescriptions

Rank: 181 out of 749

556 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

11% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 6,585 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 513 369 1 1
FUROSEMIDE 443 381 2 2
LEVOTHYROXINE SODIUM 308 286 3 13
LABETALOL HCL 276 182 4 45
HYDROCODONE-ACETAMINOPHEN 234 142 S3 5 12
CALCITRIOL 219 179 6 17
SIMVASTATIN 206 182 7 5
WARFARIN SODIUM 170 152 8 31
FAMOTIDINE 166 129 9 35
METOPROLOL TARTRATE 150 141 10 7
CALCIUM ACETATE 148 58 11 16
OMEPRAZOLE 144 109 12 6
LISINOPRIL 141 112 13 4
GABAPENTIN 136 112 14 25
ATORVASTATIN CALCIUM 134 100 15 18
LOSARTAN POTASSIUM 131 111 16 9
HYDRALAZINE HCL 120 89 17 19
ALLOPURINOL 120 96 17 10
BENAZEPRIL HCL 109 90 19 23
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 60 20 67
METFORMIN HCL 105 101 21 22
ZOLPIDEM TARTRATE 102 45 22 24
POTASSIUM CHLORIDE 98 95 23 37
CLONIDINE HCL 95 72 24 15
GLIPIZIDE 93 58 25 32
TAMSULOSIN HCL 90 81 26 29
LOVASTATIN 81 71 27 52
LANTUS 81 66 27 36
CARVEDILOL 80 46 29 11
HYDROCHLOROTHIAZIDE 73 64 30 27
CLOPIDOGREL 70 54 31 42
PREDNISONE 68 58 32 28
PRAVASTATIN SODIUM 66 48 33 49
ROPINIROLE HCL 62 47 34 132
SPIRONOLACTONE 62 60 34 44
MEGESTROL ACETATE 58 44 R 36 69
LIPITOR 55 29 37 71
ZETIA 55 55 37 80
SENSIPAR 55 17 37 8
MIRTAZAPINE 54 54 40 136
NAMENDA 52 52 41 60
HUMALOG 51 39 42 112
DIOVAN 51 50 42 14
FELODIPINE ER 50 50 44 140
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.